Samuel Rotman

Samuel Rotman

Auto-generated profile, based on publicly available information

Samuel Rotman

Service of Clinical Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
FPFrédéric Preitner
Frédéric Preitner
OBOlivier Bonny
Olivier Bonny
ALAlexandra Laverrière
Alexandra Laverrière
SRSamuel Rotman
Samuel Rotman
DFDmitri Firsov
Dmitri Firsov
BTBernard Thorens
Bernard Thorens
Elevated plasma urate levels are associated with metabolic, cardiovascular, and renal diseases. Urate may also form crystals, which can be deposited in joints causing gout and in kidney tubules inducing nephrolithiasis. In mice, plasma urate levels are controlled by hepatic breakdown, as well as, by incompletely understood renal processes of reabsorption and secretion. Here, we investigated the role of the recently identified urate transporter, Glut9, in the physiological control of urate homeostasis using mice with systemic or liver-specific inactivation of the Glut9 gene. We show that Glut9 is expressed in the basolateral membrane of hepatocytes and in both apical and basolateral membranes of the distal nephron. Mice with systemic knockout of Glut9 display moderate hyperuricemia, massive hyperuricosuria, and an early-onset nephropathy, characterized by obstructive lithiasis, tubulointerstitial inflammation, and progressive inflammatory fibrosis of the cortex, as well as, mild renal insufficiency. In contrast, liver-specific inactivation of the Glut9 gene in adult mice leads to severe hyperuricemia and hyperuricosuria, in the absence of urate nephropathy or any structural abnormality of the kidney. Together, our data show that Glut9 plays a major role in urate homeostasis by its dual role in urate handling in the kidney and uptake in the liver.

1 August 2005 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
CLCéline Leyvraz
Céline Leyvraz
RCRoch-Philippe Charles
Roch-Philippe Charles
IRIsabelle RUBERA
Isabelle RUBERA
MGMarjorie Guitard
Marjorie Guitard
SRSamuel Rotman
Samuel Rotman
EHEdith Hummler
Edith Hummler
Serine proteases are proteolytic enzymes that are involved in the regulation of various physiological processes. We generated mice lacking the membrane-anchored channel-activating serine protease (CAP) 1 (also termed protease serine S1 family member 8 [Prss8] and prostasin) in skin, and these mice died within 60 h after birth. They presented a lower body weight and exhibited severe malformation of the stratum corneum (SC). This aberrant skin development was accompanied by an impaired skin barrier function, as evidenced by dehydration and skin permeability assay and transepidermal water loss measurements leading to rapid, fatal dehydration. Analysis of differentiation markers revealed no major alterations in CAP1/Prss8-deficient skin even though the epidermal deficiency of CAP1/Prss8 expression disturbs SC lipid composition, corneocyte morphogenesis, and the processing of profilaggrin. The examination of tight junction proteins revealed an absence of occludin, which did not prevent the diffusion of subcutaneously injected tracer (∼600 D) toward the skin surface. This study shows that CAP1/Prss8 expression in the epidermis is crucial for the epidermal permeability barrier and is, thereby, indispensable for postnatal survival.

18 January 2011 in Nature Communications
Verified
Journal Article
Open access
PDF file
SFSimona Frateschi
Simona Frateschi
Eric CamererEric Camerer
Eric Camerer
GCGiovanna Crisante
Giovanna Crisante
SRSarah Rieser
Sarah Rieser
MMMathieu Membrez
Mathieu Membrez
EHEdith Hummler
Edith Hummler
Altered serine protease activity is associated with skin disorders in humans and in mice. The serine protease channel-activating protease-1 (CAP1; also termed protease serine S1 family member 8 (Prss8)) is important for epidermal homeostasis and is thus indispensable for postnatal survival in mice, but its roles and effectors in skin pathology are poorly defined. In this paper, we report that transgenic expression in mouse skin of either CAP1/Prss8 (K14-CAP1/Prss8) or protease-activated receptor-2 (PAR2; Grhl3PAR2/+), one candidate downstream target, causes epidermal hyperplasia, ichthyosis and itching. K14-CAP1/Prss8 ectopic expression impairs epidermal barrier function and causes skin inflammation characterized by an increase in thymic stromal lymphopoietin levels and immune cell infiltrations. Strikingly, both gross and functional K14-CAP1/Prss8-induced phenotypes are completely negated when superimposed on a PAR2-null background, establishing PAR2 as a pivotal mediator of pathogenesis. Our data provide genetic evidence for PAR2 as a downstream effector of CAP1/Prss8 in a signalling cascade that may provide novel therapeutic targets for ichthyoses, pruritus and inflammatory skin diseases.

28 May 2012 in Journal of Molecular Cell Biology
Verified
Journal Article
Open access
PDF file
NPNathalie Piazzon
Nathalie Piazzon
CMCharlotte Maisonneuve
Charlotte Maisonneuve
IGIsabelle Guilleret
Isabelle Guilleret
SRSamuel Rotman
Samuel Rotman
Daniel ConstamDaniel Constam
Daniel Constam
Genetic defects in autosomal-dominant polycystic kidney disease (ADPKD) promote cystic growth of renal tubules, at least in part by stimulating the accumulation of cAMP. How renal cAMP levels are regulated is incompletely understood. We show that cAMP and the expression of its synthetic enzyme adenylate cyclase-6 (AC6) are up-regulated in cystic kidneys of Bicc1−/− knockout mice. Bicc1, a protein comprising three K homology (KH) domains and a sterile alpha motif (SAM), is expressed in proximal tubules. The KH domains independently bind AC6 mRNA and recruit the miR-125a from Dicer, whereas the SAM domain enables silencing by Argonaute and TNRC6A/GW182. Bicc1 similarly induces silencing of the protein kinase inhibitor PKIα by miR-27a. Thus, Bicc1 is needed on these target mRNAs for silencing by specific miRNAs. The repression of AC6 by Bicc1 might explain why cysts in ADPKD patients preferentially arise from distal tubules.

1 June 2006 in Human Pathology
Verified
Journal Article
Closed access
VMVincent Molinié
Vincent Molinié
ABAndré Balaton
André Balaton
SRSamuel Rotman
Samuel Rotman
DMDouha Mansouri
Douha Mansouri
IPIsabelle De Pinieux
Isabelle De Pinieux
LGLouis Guillou
Louis Guillou

1 November 2011 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
AAAnnalisa Angelini
Annalisa Angelini
CAClaus Boegelund Andersen
Claus Boegelund Andersen
GBGiovanni Bartoloni
Giovanni Bartoloni
FBFiona Black
Fiona Black
PBPaul Bishop
Paul Bishop
MBMargaret Burke
Margaret Burke